Patient and kidney allograft survival with national kidney paired donation

David B. Leeser, Alvin G. Thomas, Ashton A. Shaffer, Jeffrey L. Veale, Allan B. Massie, Matthew Cooper, Sandip Kapur, Nicole Turgeon, Dorry L. Segev, Amy D. Waterman, Stuart M. Flechner

Research output: Contribution to journalArticle

Abstract

Background and objectives In the United States, kidney paired donation networks have facilitated an increasing proportion of kidney transplants annually, but transplant outcome differences beyond 5 years between paired donation and other living donor kidney transplant recipients have not been well described. Design, setting, participants, & measurements Using registry-linked data, we compared National Kidney Registry (n=2363) recipients to control kidney transplant recipients (n=54,497) (February 2008 to December 2017). We estimated the risk of death-censored graft failure and mortality using inverse probability of treatment weighted Cox regression. The parsimonious model adjusted for recipient factors (age, sex, black, race, body mass index ≥30 kg/m2, diabetes, previous transplant, preemptive transplant, public insurance, hepatitis C, eGFR, antibody depleting induction therapy, year of transplant), donor factors (age, sex, Hispanic ethnicity, body mass index ≥30 kg/m2), and transplant factors (zero HLA mismatch). Results National Kidney Registry recipients were more likely to be women, black, older, on public insurance, have panel reactive antibodies >80%, spend longer on dialysis, and be previous transplant recipients. National Kidney Registry recipients were followed for a median 3.7 years (interquartile range, 2.1–5.6; maximum 10.9 years). National Kidney Registry recipients had similar graft failure (5% versus 6%; log-rank P=0.2) and mortality (9% versus 10%; log-rank P=0.4) incidence compared with controls during follow-up. After adjustment for donor, recipient, and transplant factors, there no detectable difference in graft failure (adjusted hazard ratio, 0.95; 95% confidence interval, 0.77 to 1.18; P=0.6) or mortality (adjusted hazard ratio, 0.86; 95% confidence interval, 0.70 to 1.07; P=0.2) between National Kidney Registry and control recipients. Conclusions Even after transplanting patients with greater risk factors for worse post-transplant outcomes, nationalized paired donation results in equivalent outcomes when compared with control living donor kidney transplant recipients.

Original languageEnglish (US)
Pages (from-to)228-237
Number of pages10
JournalClinical Journal of the American Society of Nephrology
Volume15
Issue number2
DOIs
StatePublished - Feb 7 2020

ASJC Scopus subject areas

  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Nephrology
  • Transplantation

Fingerprint Dive into the research topics of 'Patient and kidney allograft survival with national kidney paired donation'. Together they form a unique fingerprint.

  • Cite this

    Leeser, D. B., Thomas, A. G., Shaffer, A. A., Veale, J. L., Massie, A. B., Cooper, M., Kapur, S., Turgeon, N., Segev, D. L., Waterman, A. D., & Flechner, S. M. (2020). Patient and kidney allograft survival with national kidney paired donation. Clinical Journal of the American Society of Nephrology, 15(2), 228-237. https://doi.org/10.2215/CJN.06660619